I would just ignore the Chinese investment firm (most of these "firms" are not easy but nasty to deal with even though they are for real). Execution is the key. This is the work used to be executed by SNY and now by MNKD on its own with 100% effort and dedication!
I see a new management formed this year. Those things you mentioned have been done. I see new faces and new plans, viable, realistic and achievable.
Henry Orlosky used to be the CEO U.S. Solar Energy Corp. That's all I have. Nothing else is searched regarding the fund.
Realistically, this is a question no one can give you answer at this point of time. Things just started being coordinated and executed. Let's wait for a couple of quarters and we'll have a rough picture to your question.
Maybe you are the brightest guy here. If you have no confidence in this company and the management, you may short sell it now. I have no problem with this.
Maybe you can learn more about what the management and shareholders had said in the ASM to get more update.
Matt dis not misjudge. He told the guy it was not a question and moved on with next one.
I do not take that "statement" too seriously. Nothing said was substantial. It was purely an indication of an investment company which show some interest in MNKD.
All ABM are being newly recruited for the launch & sales of Afrezza. So you won't be meeting the same rep.
60 jobs (Area Business Managers) available for launch of an innovative treatment for diabetes.
"We wish to become a multinational pharma company by tapping the foreign markets. At the same time, we aim to place our self amongst the top three pharmaceutical companies of India,"
Apparent to me this is an indian company with a name similar to Mannkind. Nothing to do with MNKD.